Literature DB >> 28063765

Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.

Rabia Bentata1, Audrey Cougnard-Grégoire2, Marie Noëlle Delyfer3, Cécile Delcourt2, Laurence Blanco4, Emilie Pupier4, Marie Bénédicte Rougier3, Kalina Rajaobelina2, Marie Hugo4, Jean François Korobelnik3, Vincent Rigalleau5.   

Abstract

OBJECTIVES: Advanced glycation end-products (AGEs) are involved in diabetic retinopathy (DR). Their accumulation in tissues can be analyzed by measuring the skin autofluorescence (sAF). We hypothesized that renal insufficiency, another cause of high sAF, may disturb the relation between sAF and DR. RESEARCH DESIGN AND METHODS: We measured sAF with an AGE-Reader in 444 patients with type 2 diabetes (T2D), and we analyzed their retinal status. The associations of sAF with DR, and interaction with renal insufficiency were estimated by multivariate logistic regression analysis.
RESULTS: Mean age was 62years (standard deviation (SD) 10years), diabetes duration 13 (9) years and mean HbA1C 8.9% (1.8). The prevalence of DR was 21.4% and increased with age, diabetes duration, arterial hypertension, renal parameters (serum creatinine and albumin excretion rates), and sAF. The prevalence of macular edema (ME) was 8.6% and increased with the duration of diabetes, but not with sAF (p=0.11). There was a significant interaction between renal insufficiency and sAF for the relation with DR or ME (p=0.02). For the 83% patients without renal insufficiency (estimated GFR>60mL/min/1.73m2), sAF was related to DR or ME after multivariate adjustment: OR 1.87 (1.09-3.19). The 17% patients with renal insufficiency had the highest rates of DR or ME (38.6%) and the highest sAF, unrelated to each other.
CONCLUSIONS: In T2D patients with renal insufficiency, the high sAF does not relate to retinopathy, which should be systematically searched due to its high frequency. For other patients, a high sAF argues for DR screening.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  nephropathy; retinopathy; skin autofluorescence; type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 28063765     DOI: 10.1016/j.jdiacomp.2016.10.028

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  4 in total

1.  Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518-2526.

Authors:  Jennifer Lopez; William S Gange; Khristina Lung; Benjamin Y Xu; Seth A Seabury; Brian C Toy
Journal:  Diabetes Care       Date:  2022-03-01       Impact factor: 19.112

2.  Fingertip-Measured Skin Carotenoids and Advanced Glycation End Product Levels in Glaucoma.

Authors:  Yoichi Kadoh; Yuji Takayanagi; Junichi Sasaki; Masaki Tanito
Journal:  Antioxidants (Basel)       Date:  2022-06-09

Review 3.  Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes.

Authors:  Alejandra Planas; Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 4.  Skin AGEs and diabetic neuropathy.

Authors:  Stella Papachristou; Kalliopi Pafili; Nikolaos Papanas
Journal:  BMC Endocr Disord       Date:  2021-02-23       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.